Review




Structured Review

Spatial Transcriptomics Inc whole transcriptome sequencing wts
Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA <t>sequencing</t> (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.
Whole Transcriptome Sequencing Wts, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+transcriptome+sequencing+wts/pmc12360329-5-6-21?v=Spatial+Transcriptomics+Inc
Average 86 stars, based on 1 article reviews
whole transcriptome sequencing wts - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "Novel cancer‐associated secretory cells and IL‐1β + macrophages as key players in early lung adenocarcinoma progression in female never‐smokers"

Article Title: Novel cancer‐associated secretory cells and IL‐1β + macrophages as key players in early lung adenocarcinoma progression in female never‐smokers

Journal: Clinical and Translational Medicine

doi: 10.1002/ctm2.70433

Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA sequencing (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.
Figure Legend Snippet: Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA sequencing (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.

Techniques Used: Gene Expression, Marker, Expressing, RNA Sequencing, Sequencing



Similar Products

86
Caris Life Sciences whole transcriptome sequencing wts
Whole Transcriptome Sequencing Wts, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+transcriptome+sequencing+wts/pm41905669-47-18-22?v=Caris+Life+Sciences
Average 86 stars, based on 1 article reviews
whole transcriptome sequencing wts - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Spatial Transcriptomics Inc whole transcriptome sequencing wts
Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA <t>sequencing</t> (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.
Whole Transcriptome Sequencing Wts, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+transcriptome+sequencing+wts/pmc12360329-5-6-21?v=Spatial+Transcriptomics+Inc
Average 86 stars, based on 1 article reviews
whole transcriptome sequencing wts - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Illumina Inc whole transcriptome sequencing (wts) using the illumina novaseq x plus platform
Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA <t>sequencing</t> (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.
Whole Transcriptome Sequencing (Wts) Using The Illumina Novaseq X Plus Platform, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+transcriptome+sequencing+wts/pm40304116-99-18-17?v=Illumina+Inc
Average 90 stars, based on 1 article reviews
whole transcriptome sequencing (wts) using the illumina novaseq x plus platform - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Illumina Inc whole transcriptome sequencing (wts)
Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA <t>sequencing</t> (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.
Whole Transcriptome Sequencing (Wts), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+transcriptome+sequencing+wts/pm39804544-43-5-16?v=Illumina+Inc
Average 90 stars, based on 1 article reviews
whole transcriptome sequencing (wts) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Caris Life Sciences whole-transcriptome sequencing (wts
Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA <t>sequencing</t> (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.
Whole Transcriptome Sequencing (Wts, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+transcriptome+sequencing+wts/pmc11640466-46-26-38?v=Caris+Life+Sciences
Average 90 stars, based on 1 article reviews
whole-transcriptome sequencing (wts - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Illumina Inc whole transcriptome sequencing (wts) on illumina novaseq 6500
Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA <t>sequencing</t> (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.
Whole Transcriptome Sequencing (Wts) On Illumina Novaseq 6500, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+transcriptome+sequencing+wts/pmc11175596-605-5-5?v=Illumina+Inc
Average 90 stars, based on 1 article reviews
whole transcriptome sequencing (wts) on illumina novaseq 6500 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA sequencing (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.

Journal: Clinical and Translational Medicine

Article Title: Novel cancer‐associated secretory cells and IL‐1β + macrophages as key players in early lung adenocarcinoma progression in female never‐smokers

doi: 10.1002/ctm2.70433

Figure Lengend Snippet: Cancer‐associated secretory (CAS) cells originated from alveolar type 2 (AT2) cells. (A) Principal component analysis (PCA) plot of alveolar type 1 (AT1), AT2 and CAS cells in the solid component of tumour (S) and ground‐glass component of tumour (GG) regions, with lines representing the inferred trajectories. Each dot represents a single cell and is coloured according to cell type. Lines indicate inferred trajectories, estimated using Slingshot. (B) PCA plots of single‐cell transcriptomes, with cells (dots) coloured by region (GG vs. S) (top) and patient (bottom). (C) Pseudotime analysis depicting the gene expression dynamics of surfactant protein A1 (SFTPA1) (AT2 marker), advanced glycation end‐product specific receptor (AGER) (AT1 marker), secretoglobin family 3A member 2 (SCGB3A2) (CAS marker) and carcinoembryonic antigen‐related cell adhesion molecule 6 (CEACAM6) (CAS marker) along the inferred trajectory. The black line and points represent lineage 1 (AT2 to AT1), while the red line and points represent lineage 2 (AT2 to CAS). (D) Violin plots showing the expression levels of carcinoembryonic antigen‐related cell adhesion molecule 5 (CEACAM5), CEACAM6 and serine peptidase inhibitor Kazal type 1 (SPINK1) across different samples in CAS cell types from single‐cell RNA sequencing (scRNA‐seq). (E) Box plots displaying normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across different components (N, GG and S, n = 7, respectively) in whole‐transcriptome sequencing analysis. The Kruskal–Wallis test was performed. (F) Box plots showing the normalised expression levels of SFTPA1, SCGB3A2, CEACAM5, CEACAM6 and SPINK1 across normal (N, n = 23) and cancer (C, n = 34) tissues from a study by Zhang et al. (2020). Wilcox statistical significance is indicated by p ‐values. PSN, part‐solid nodule; SCGB3A1, secretoglobin family 3A member 1.

Article Snippet: Analyses included whole‐exome sequencing (WES) and whole‐transcriptome sequencing (WTS) ( n = 7), single‐cell RNA sequencing ( n = 4) and spatial transcriptomics ( n = 1, SMC‐19) (Figure ).

Techniques: Gene Expression, Marker, Expressing, RNA Sequencing, Sequencing